Suchergebnisse - "Viney, Nicholas J"

PubPharm (70)

1

Modulación de la expresión de apolipoproteína C-III (APOCIII) en poblaciones deficientes en lipoproteína lipasa (LPLD)

enthalten in: Europäisches Patentamt | 2024

von ALEXANDER VERONICA J | VINEY NICHOLAS J | WITZTUM JOSEPH L

2

Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy

enthalten in: JAMA | 2023

von Coelho, T. | Marques, W. | Dasgupta, N. | +54

CommentIn: JAMA. 2023 Oct 17;330(15):1433-1434. - PMID 37768648

3

MODULATION OF APOLIPOPROTEIN C-III (APOCIII) EXPRESSION IN LIPOPROTEIN LIPASE DEFICIENT (LPLD) POPULATIONS

enthalten in: Europäisches Patentamt | 2023

von ALEXANDER VERONICA J | VINEY NICHOLAS J | WITZTUM JOSEPH L

4

COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PREKALLIKREIN-ASSOCIATED CONDITIONS

enthalten in: Europäisches Patentamt | 2023

von SCHNEIDER EUGENE | VINEY NICHOLAS J | ALEXANDRA VERONICA J | +2

5

Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen

enthalten in: Neurology and therapy | 2023

von Coelho, T. | Waddington Cruz, M. | Chao, C. | +15

6

CONJUGATED ANTISENSE COMPOUNDS FOR USE IN THERAPY

enthalten in: Europäisches Patentamt | 2023

von VINEY NICHOLAS J | GEARY RICHARD S | WANG YANFENG | +2

7

Eplontersen for hereditary transthyretin amyloidosis with polyneuropathy

enthalten in: The journal of the American Medical Association | September 28, 2023

von Coelho, T. | Marques, W. | Dasgupta, N. | +27

8

Population pharmacokinetic/pharmacodynamic modelling of eplontersen, an antisense oligonucleotide in development for transthyretin amyloidosis

enthalten in: British journal of clinical pharmacology | 2022

von Diep, J. | Yu, R. | Viney, N. | +6

9

Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen

enthalten in: Neurology and Therapy | 2022

von Coelho, T. | Waddington Cruz, M. | Chao, C. | +15

10

Characteristics of Patients with Hereditary Transthyretin Amyloidosis-Polyneuropathy (ATTRv-PN) in NEURO-TTRansform, an Open-label Phase 3 Study of Eplontersen

enthalten in: Neurology and Therapy | 2022

von Coelho, T. | Waddington Cruz, M. | Chao, C. | +15

1
2
3
4
5
6
7
Nächster »
[7]